While we found that K147 can negatively regulate KRAS expression, there are no reported KRAS K147 mutations among MM tumors profiled in the Multiple Myeloma Research Foundation (MMRF) CoMMpass study38. This evidence concerns the gene KRAS and Miyoshi myopathy.